To add to my comment above, I just read how the CDC is refusing to support the "booster" for Pfizer, saying a decrease in antibodies is not sufficient to justify another round of doses. Plus, Pharma in the UK is advertising how mixing brands provides superior immunity, which seems nonsensical. But, it seems as though Novavax may be the up and coming "cash cow" for this Fall/Winter.
To add to my comment above, I just read how the CDC is refusing to support the "booster" for Pfizer, saying a decrease in antibodies is not sufficient to justify another round of doses. Plus, Pharma in the UK is advertising how mixing brands provides superior immunity, which seems nonsensical. But, it seems as though Novavax may be the up and coming "cash cow" for this Fall/Winter.
https://childrenshealthdefense.org/defender/cdc-experts-disagree-pfizer-covid-boosters/
"CDC Experts Disagree With Pfizer on COVID Boosters, Threatening Pharma Giant’s Billion Dollar Revenue Stream"